Leading-Edge SARS-CoV-2 Testing

Addressing the Ongoing Pandemic

As many continue to tackle the day-to-day battle against COVID-19, it’s critical that we share the latest insights into the disease to ensure mutual understanding and learning. The coming winter will put management of both COVID-19 and flu infections at the forefront of healthcare challenges, where leading-edge thinking may be the only route to helping healthcare providers save lives and protect communities.

This P.A.C.E.-accredited Fisher Healthcare webinar will be a scientific exchange of insights from Jeff Andrews, MD, FRCSC, a leading expert in molecular diagnostics. He will review the relevant basics of the COVID-19 disease and the SARS-CoV-2 virus, including the incubation period, pre-symptomatic period, symptomatic phase, and asymptomatic infections. Dr. Andrews will also plot the patterns of viral load, antigen sensitivity, PCR sensitivity, and antibody sensitivity.

Learning Objectives

This webinar will help you:

• Identify what we know about influenza vs. COVID-19 and SARS-CoV-2
• Explore insights to inform the next 12 months and discuss the forecasted impact of COVID-19
• Explain the role of diagnostics and the available options for diagnosing and treating COVID-19

Watch on Demand      Download Slides (PDF, 2MB)

This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E.™ Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.

The views expressed in this webinar represent those of the presenter and do not necessarily reflect the viewpoints of the Fisher Healthcare channel.

Jeff Andrews, MD, FRCSC

Dr. Andrews is the Worldwide Medical Director for Women’s Health and Cancer at BD Life Sciences. As a board-certified obstetrician and gynecologist, he has provided care in community settings in both Toronto and Washington, D.C. He has also provided care in academic settings as an Associate Professor at Duke University Medical Center and Vanderbilt University Medical Center.

Dr. Andrews has held prestigious roles at several academic centers, and before joining BD he was the Chief Medical Research Advisor for the American Society for Colposcopy and Cervical Pathology. At BD, he focuses on molecular diagnostics, the prevention of cervical cancer through early detection of cancer precursors, and novel approaches to diagnosing infectious diseases in women. In 2020, Dr. Andrews has been working with the BD teams delivering SARS-CoV-2 diagnostics to meet the needs for molecular testing and rapid point-of-care testing.